分析物
免疫分析
药品
滥用药物
尿
苯环己定
麦角酸二乙酰胺
毒品检测
色谱法
三环
化学
药理学
医学
内科学
免疫学
抗体
NMDA受体
受体
血清素
作者
Alec Saitman,H.-D. Park,Robert L. Fitzgerald
摘要
Urine drug screen (UDS) immunoassays are a quick and inexpensive method for determining the presence of drugs of abuse. Many cross-reactivities exist with other analytes, potentially causing a false-positive result in an initial drug screen. Knowledge of these potential interferents is important in determining a course of action for patient care. We present an inclusive review of analytes causing false-positive interferences with drugs-of-abuse UDS immunoassays, which covers the literature from the year 2000 to present. English language articles were searched via the SciFinder platform with the strings ‘false positive [drug] urine’ yielding 173 articles. These articles were then carefully analyzed and condensed to 62 that included data on causes of false-positive results. The discussion is separated into six sections by drug class with a corresponding table of cross-reacting compounds for quick reference. False-positive results were described for amphetamines, opiates, benzodiazepines, cannabinoids, tricyclic antidepressants, phencyclidine, lysergic acid diethylamide and barbiturates. These false-positive results support the generally accepted practice that immunoassay positive results are considered presumptive until confirmed by a second independent chemical technique.
科研通智能强力驱动
Strongly Powered by AbleSci AI